October 2022 - Page 2 of 3 - BioMedWire (BMW)

TuesdayOct 18, 2022 2:23 pm

Cancer Studies Provide Researchers with New Information on Ovarian Cancer Development, Growth

Two studies recently conducted by Cedars-Sinai Cancer scientists have discovered new information that may improve the understanding of why some patients don’t respond to treatment and what drives ovarian cancer development. Epithelial ovarian cancer is the most common ovarian cancer type, developing in the epithelial tissue. It is estimated that roughly 85% of ovarian tumors are epithelial. The first study affords researchers a better understanding into how ovarian tumors develop resistance to treatment. Resistance usually develops in nearly 80% of high-grade serous tumors of patients with ovarian cancer. The co-first author for this study, Michelle Jones, stated that whole genome…

TuesdayOct 18, 2022 9:45 am

Odyssey Health, Inc. (ODYY) Updates Progress of its Concussion Drug Development Program; Communicating with the FDA for permission to start phase II clinical trial of its PRV-002 Drug Candidate

Odyssey acquired IP and all rights to PRV-002, its lead drug candidate for the treatment of concussions, on March 1, 2021, and has since made notable progress in a strategic move to have the drug approved by the FDA Since the acquisition, the company has completed IND enabling studies and all cohorts for Phase I SAD and MAD clinical trials for its lead drug candidate In pre-clinical studies PRV-002 has demonstrated equivalent, if not superior neuroprotective effects compared to related neurosteroids, offering proof of reduced behavioral pathology associated with brain injury symptoms, easily crossing the blood-brain barrier to rapidly eliminate…

MondayOct 17, 2022 11:04 am

Researchers Develop AI Tool That Scans Retina, Detects Heart Disease in One Minute

Heart disease, which is estimated to take around 17.9 million lives annually, is among the leading causes of death across the world. This condition commonly affects people aged 20 and older across the united States, with one American suffering a heart attack every 40 seconds. In total, roughly 800,000 individuals suffer heart attacks every year. Although heart diseases such as coronary artery disease cannot be cured, early detection can allow for the management of symptoms to reduce a patient’s chances of having a heart attack. Researchers have now developed software that could allow physicians to detect heart disease in only…

FridayOct 14, 2022 12:59 pm

Allergies: How They Occur and Why They Sometimes Disappear

Allergies occur when an individual’s immune system reacts to any substance, including dust, pollen or animal fur, flagging the substance as dangerous and attacking it as a protective measure. When the body attacks the substance, referred to as an allergen, it prompts the immune system to release IgE antibodies. This in turn prompts the release of histamine, which causes an allergic reaction that results in swelling, redness and itching. In extreme cases, allergic reactions can lead to death. Pet allergies in particular are common especially in young children, with fur being enough to cause an allergic reaction. Common symptoms include…

FridayOct 14, 2022 10:30 am

Odyssey Health, Inc. (ODYY) Seeking to Provide Solution to Concussion-Prone Military and NFL with Development of PRV-002 Drug Candidate

Odyssey Health is a medical company developing unique, life-saving products that address unmet clinical needs such as concussion, which does not have an FDA-approved therapeutic The company has developed PRV-002, a neurosteroid for the treatment of concussion, and an intranasal delivery device that delivers the drug into the upper chamber of the nasal cavity for onward travel into the brain Odyssey’s just concluded Phase I clinical trial shows that PRV-002 is safe and well tolerated The findings from the study are likely to benefit the military as well as the NFL, given military personnel and players frequently suffer concussions In…

ThursdayOct 13, 2022 11:49 am

Researchers Uncover Vital Clues on Drivers Behind Growth, Size of Brain Tumors

A new study has discovered a crucial new piece of information for the treatment and prevention of brain tumors. The study was led by Mount Sinai Hospital’s Lunenfeld-Tannenbaum Research Institute, in collaboration with the Mayo Clinic Center for Individualized Medicine and the Mayo Clinic Comprehensive Cancer Center. Its findings were reported in the Science journal. Gliomas are a type of tumor that occur in the brain and spinal cord. These tumors usually start to develop in the glial cells, which help nerve cells function. The average length of survival for patients with these tumors is estimated at eight months with…

WednesdayOct 12, 2022 1:44 pm

Study Finds Coffee Consumption Reduces Risk of Cardiac Problems

New research has found that drinking two to three cups of coffee a day may protect an individual from cardiovascular illness and even an early death. Peter Kistler, head of clinical electrophysiology research at the Baker Heart and Diabetes Institute and author of the study, stated that findings suggest that the moderate consumption of instant, ground and decaffeinated coffee was part of a healthy lifestyle. Kistler explained that while coffee contained caffeine, which was well-known, it also contained more than 100 other biologically active components. Prior research has found that the mild intake of black coffee, which constitutes three to…

TuesdayOct 11, 2022 1:36 pm

New Report Praises Advances in Cancer Treatment for Preventing Millions of Deaths

A new report has highlighted that the rate of death due to cancer in America has steadily declined in the last few decades. As of January 2022, more than 18 million individuals who have survived cancer live in America. This is a new record, especially if one compares the figures against the 3 million survivors recorded in the U.S. in 1971. Researchers predict that by 2040, this number will have reached 24 million. The report, which was released late last month by the American Association for Cancer Research, notes that the number of individuals who survived after receiving their diagnosis…

MondayOct 10, 2022 12:21 pm

Helmets Will Not Protect Individuals Against Concussions, Expert Says

Concussions are a type of brain injury that occurs when the head is struck hard enough that the brain smacks against the skull and is damaged. Such injuries can also happen when the body is shaken violently enough to cause the brain to move around in the skull, such as during whiplash. As with most head injuries, concussions can have major consequences if they are severe or not treated early enough. Over the long term, some patients may develop a condition called post-concussion syndrome, which is characterized by dizziness, headaches and problems with memory and concentration. Aside from car accidents,…

MondayOct 10, 2022 9:00 am

Odyssey Health, Inc. (ODYY) PRV-002 Compound Takes on Heightened Significance Following Recent Concussion of Dolphins Quarterback Tua Tagovailoa, and the NFL and NFLPA’s Announcement on Changes to Concussion Protocol

The concussion controversy surrounding Tua Tagovailoa has prompted both the NFL and the NFLPA to revisit the league’s concussion protocol in a move designed to enhance player safety In the wake of this controversy, Odyssey is emphasizing the potential value of its PRV-002 novel compound for the treatment of concussions and the benefit of the players According to a report published by Vox, there are approximately 0.41 concussions per NFL game in American football, with 9.3% of concussions involving the loss of consciousness and 2.4% resulting in hospitalizations With such cases, there is a need to revise the NFL’s concussion…

News and publishing service for medical and biotechnology related companies

Contact us: 415.949.5050

Month: October 2022

Cancer Studies Provide Researchers with New Information on Ovarian Cancer Development, Growth

Odyssey Health, Inc. (ODYY) Updates Progress of its Concussion Drug Development Program; Communicating with the FDA for permission to start phase II clinical trial of its PRV-002 Drug Candidate

Researchers Develop AI Tool That Scans Retina, Detects Heart Disease in One Minute

Allergies: How They Occur and Why They Sometimes Disappear

Odyssey Health, Inc. (ODYY) Seeking to Provide Solution to Concussion-Prone Military and NFL with Development of PRV-002 Drug Candidate

Researchers Uncover Vital Clues on Drivers Behind Growth, Size of Brain Tumors

Study Finds Coffee Consumption Reduces Risk of Cardiac Problems

New Report Praises Advances in Cancer Treatment for Preventing Millions of Deaths

Helmets Will Not Protect Individuals Against Concussions, Expert Says

Odyssey Health, Inc. (ODYY) PRV-002 Compound Takes on Heightened Significance Following Recent Concussion of Dolphins Quarterback Tua Tagovailoa, and the NFL and NFLPA’s Announcement on Changes to Concussion Protocol

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search